Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 WOCKHARDT   TEVA PHARMA
EQUITY SHARE DATA
    WOCKHARDT
Mar-23
TEVA PHARMA
Dec-13
WOCKHARDT/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs3163,479-   
Low Rs1453,022-   
Sales per share (Unadj.) Rs184.01,996.4-  
Earnings per share (Unadj.) Rs-43.1124.7-  
Cash flow per share (Unadj.) Rs-25.7286.1-  
Dividends per share (Unadj.) Rs0109.18-  
Avg Dividend yield %03.4 0.0%  
Book value per share (Unadj.) Rs231.72,217.6-  
Shares outstanding (eoy) m144.09848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.31.6 76.9%   
Avg P/E ratio x-5.326.1 -20.5%  
P/CF ratio (eoy) x-9.011.4 -79.0%  
Price / Book Value ratio x1.01.5 67.9%  
Dividend payout %087.5 -0.0%   
Avg Mkt Cap Rs m33,2022,756,220 1.2%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m6,3700-   
Avg. sales/employee Rs Th037,667.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,353.1-  
INCOME DATA
Net Sales Rs m26,5101,692,969 1.6%  
Other income Rs m1,2200-   
Total revenues Rs m27,7301,692,969 1.6%   
Gross profit Rs m-1,930463,620 -0.4%  
Depreciation Rs m2,510136,844 1.8%   
Interest Rs m3,02033,253 9.1%   
Profit before tax Rs m-6,240293,523 -2.1%   
Minority Interest Rs m01,333 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,682 -0.0%   
Tax Rs m-30-3,584 0.8%   
Profit after tax Rs m-6,210105,758 -5.9%  
Gross profit margin %-7.327.4 -26.6%  
Effective tax rate %0.5-1.2 -39.4%   
Net profit margin %-23.46.2 -375.0%  
BALANCE SHEET DATA
Current assets Rs m19,1401,143,425 1.7%   
Current liabilities Rs m34,350997,163 3.4%   
Net working cap to sales %-57.48.6 -664.1%  
Current ratio x0.61.1 48.6%  
Inventory Days Days3991 43.4%  
Debtors Days Days1196 11.4%  
Net fixed assets Rs m48,670552,961 8.8%   
Share capital Rs m7204,167 17.3%   
"Free" reserves Rs m32,6600-   
Net worth Rs m33,3801,880,567 1.8%   
Long term debt Rs m2,240865,653 0.3%   
Total assets Rs m70,7503,868,976 1.8%  
Interest coverage x-1.19.8 -10.8%   
Debt to equity ratio x0.10.5 14.6%  
Sales to assets ratio x0.40.4 85.6%   
Return on assets %-4.53.6 -125.5%  
Return on equity %-18.65.6 -330.8%  
Return on capital %-9.04.9 -183.3%  
Exports to sales %00-   
Imports to sales %3.50-   
Net fx Rs m-1900-   
CASH FLOW
From Operations Rs m1,530269,772 0.6%  
From Investments Rs m-1,250-95,591 1.3%  
From Financial Activity Rs m-3,150-323,609 1.0%  
Net Cashflow Rs m-2,800-149,429 1.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare WOCKHARDT With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare WOCKHARDT With: IPCA LABS  GUFIC BIOSCIENCE  ALPA LAB  FDC  LINCOLN PHAR  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.